EI
OXFD

EAM Investors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

EAM Investors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-59,873
Closed -$1.03M – 331
2019
Q1 		$1.03M Buy
+59,873
New +$948K 0.25% 184
2017
Q4 		– Sell
-120,397
Closed -$2.02M – 376
2017
Q3 		$2.02M Buy
+120,397
New +$1.96M 0.27% 192

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

EAM Investors's OXFD Position: Q2 2019 in Review

EAM Investors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2019, closing a stake of 59,873 shares — an estimated $1.03M sold.

EAM Investors first reported a position in OXFD in Q3 2017 and held it in 2 quarters. The position peaked at $2.02M in Q3 2017. 86 funds tracked by Wall St. Rank hold OXFD as of Q2 2019.

  • EAM Investors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • EAM Investors sold 59,873 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2019, an estimated $1.03M.
  • EAM Investors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2017 and held it in 2 quarters.
  • EAM Investors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.02M in Q3 2017.
  • 86 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2019.

Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.